Merck sues government over Medicare drug pricing, claiming "extortion"
Drugmaker Merck is suing the U.S. government over its plan to allow Medicare to negotiate prices for a handful of drugs, calling it "extortion." The plan, part of the 2022 Inflation Reduction Act, is expected to save taxpayers billions of dollars on common drugs the government pays for. The law…
#drugmakermerck #medicare #centerformedicare #medicaidservices #districtofcolumbia #merck #janumet #newjersey #xavierbecerra #hhs